Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
Clinical trial NCT00713219 · COMPLETED
Trial details
- NCT number
- NCT00713219
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2013-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.